HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic targets and molecular mechanism of calycosin for the treatment of cerebral ischemia/reperfusion injury.

Abstract
This study was designed to understand the pivotal anti-cerebral ischemia/reperfusion injury (CIRI) targets and pathways of calycosin through network pharmacology and molecular docking analyses. In this study, bioinformatics tools were employed to characterize and identify the pharmacological functions and mechanisms of calycosin for CIRI management. The network pharmacology data identified potential, merged CIRI-associated targets of calycosin including tumor protein p53 (TP53), protein kinase B (AKT1), vascular endothelial growth factor A (VEGFA), interleukin 6, tumor necrosis factor (TNF), and mitogen-activated protein kinase 1 (MAPK1). Molecular docking analysis indicated the binding efficacy of calycosin with three of the targets, namely TP53, AKT1, and VEGFA. The biological processes of calycosin for the treatment of CIRI are mainly involved in the improvement of endothelial cell proliferation and growth, inflammatory development, and cellular metabolism. In addition, the anti-CIRI actions of calycosin were primarily through suppression of the toll-like receptor, PI3K-AKT, TNF, MAPK, and VEGF signaling pathways. Taken together, the current bioinformatic findings revealed pivotal targets, biological functions, and pharmacological mechanisms of calycosin for the treatment of CIRI. In conclusion, calycosin, a functional phytoestrogen, can be potentially used for the treatment of CIRI in future clinical trials.
AuthorsSongzuo Yu, Ka Wu, Yujia Liang, Haitao Zhang, Chao Guo, Bin Yang
JournalAging (Aging (Albany NY)) Vol. 13 Issue 12 Pg. 16804-16815 (06 27 2021) ISSN: 1945-4589 [Electronic] United States
PMID34176787 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Isoflavones
  • 7,3'-dihydroxy-4'-methoxyisoflavone
Topics
  • Algorithms
  • Brain Ischemia (complications, drug therapy)
  • Cluster Analysis
  • Humans
  • Isoflavones (therapeutic use)
  • Molecular Docking Simulation
  • Molecular Targeted Therapy
  • Reperfusion Injury (complications, drug therapy)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: